CLINICAL TRIALS PROFILE FOR ETOMIDATE
✉ Email this page to a colleague
All Clinical Trials for ETOMIDATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00175747 ↗ | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | Completed | National Cancer Institute (NCI) | Phase 2/Phase 3 | 2000-01-01 | Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia. |
| NCT00175747 ↗ | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | Completed | University of British Columbia | Phase 2/Phase 3 | 2000-01-01 | Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia. |
| NCT00248729 ↗ | Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital. | Completed | St. Luke's Hospital, Pennsylvania | Phase 2 | 2002-10-01 | The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance. |
| NCT00415701 ↗ | Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery | Completed | University Hospital Inselspital, Berne | Phase 4 | 2006-11-01 | The purpose of this study is to evaluate the effect of a single dose of etomidate for patients undergoing cardiac surgery with the use of cardiopulmonary bypass (CPB) on post-CPB adrenocortical responsiveness, on requirements of hemodynamic support, and on use of intensive care resources. |
| NCT00440102 ↗ | Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity | Completed | Assistance Publique - Hôpitaux de Paris | Phase 4 | 2007-04-01 | The expected benefit is a reduction of the morbidity of patients admitted in the intensive care unit having received ketamine for intubation. |
| NCT00441792 ↗ | The Effect of Etomidate on Patient Outcomes After Single Bolus Doses | Completed | Emergency Medicine Foundation | N/A | 2007-10-01 | The primary aim is to determine the difference in hospital length of stay between septic patients given etomidate and those given midazolam for induction during rapid sequence intubation (RSI) in the emergency department. To achieve this aim we plan to perform a prospective randomized trial measuring the length of stay of patients meeting sepsis criteria and requiring intubation. The investigators will compare in-hospital mortality rates between patients given etomidate and patients given midazolam for induction. In addition to hospital length of stay, secondary endpoints between the two groups will include length of stay in the intensive care unit, death within 48 hours of admission, and total number of days intubated. Research Hypothesis: In adult patients presenting to the emergency department with sepsis and requiring rapid sequence intubation, the length of stay of patients given etomidate will be greater than that of patients given the alternative agent midazolam for induction. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ETOMIDATE
Condition Name
Clinical Trial Locations for ETOMIDATE
Trials by Country
Clinical Trial Progress for ETOMIDATE
Clinical Trial Phase
Clinical Trial Sponsors for ETOMIDATE
Sponsor Name
